Notable updates, news, or analysts actions from our trading lists followed by 'Our Take'.Omeros announces narsoplimab BLA accepted by FDA Omeros Corporation announced that the biologics license application, or BLA, for narsoplimab for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy, or HSCT-TMA, has been accepted for filing by the FDA. The BLA has been granted priority review with an FDA action date of July 17 under the Prescription Drug User Fee Act, or PDUFA. FDA also indicated in its filing letter that the Agency is not currently planning to hold an advisory committee meeting to discuss the BLA.Our Take: Looks good. The stock popped today, we would wait for a pullback before starting a new position. If already in it, we would take some profits by selling a bit or by selling some covered callsTG Therapeutics price target raised to $78 from $61 at H.C. WainwrightH.C. Wainwright analyst Edward White raised the firm's price target on TG Therapeutics to $78 from $61 and keeps a Buy rating on the shares. The analyst sees "many catalysts" in 2021. He reminds investors that the umbralisib submission in marginal zone lymphoma has been accepted by the FDA for priority review with a PDUFA date of February 15.Our Take: Still our top pick. Like this analyst points out, there are many catalysts this year to jump this stock higher. $TGTX, TG Therapeutics, Inc. / H1 Disclosure: I may trade in the ticker symbols mentioned, both long or short. My articles represent my personal opinion and analysis and should not be taken as investment advice. Readers should do their own research before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal. If you liked this article, please click the LIKE (thumbs up) button. Feel free to leave any comments, question, or opinions. (Sign-up if you haven't already done so). Follow us/bookmark us and check back occasionally for additional articles or comments on our page... Wild Tiger Trading - start/main page. .